Autologous plasma therapy
Mode of action & area of application
ÜBERSICHT
Therapy procedure
In autologous plasma therapy ACP (autologous conditioned plasma), approx. 10-15 ml of blood is first taken from the patient’s arm vein. The valuable growth factors and platelets, which play a key biochemical role in regeneration and healing, are separated from the remaining blood components in a centrifuge. This process takes about 10 minutes. The blood platelets are then injected directly into the affected diseased area or into the arthritic joint at a concentration of approx. 3 times the normal level.
Usually 3-5 treatments at intervals of 1-2 weeks are required to achieve the desired effect.
How does ACP therapy work?
Centrifugation produces a plasma with an approx. 3-fold blood platelet concentrate. Outside the body, the leaflets are activated and release a number of growth factors. These growth factors are intended to promote the proliferation of various cells (e.g. stem cells, cartilage cells, etc.), increase the formation of new blood vessels and, in particular, have an anti-inflammatory effect.
Advantages of ACP therapy
The body’s own growth factors are used to accelerate or improve healing processes. It is therefore a very safe method compared to other forms of therapy.
There are various providers and auto-plasma systems on the market. I use ACP technology because it is a closed system and no external contamination can occur. This is a significant advantage compared to other systems, as the safety of my patients is most important to me.
Areas of application of ACP therapy
- Arthrosis therapy, cartilage damage
- Tendon insertion irritations, e.g. tennis elbow, patellar tendon
- Overload syndromes e.g. plantar fascia irritation
- Muscle injuries
